{ "market" : {"NAME" : "U.S.", "ID" : "us_market", "TZ" : "ET", "TZOFFSET" : "-18000", "open" : "1259159420", "close" : "1259182820", "flags" : {}} , "STREAMER_SERVER" : "http://streamerapi.finance.yahoo.com","arrowAsChangeSign" : false,"throttleInterval": "1000"}
indieresearch

Stocks End Mixed, Bullish Momentum Remains Intact

  • On 4:41 pm EDT, Tuesday October 13, 2009

Stocks slumbered through the day, eventually ending mixed. The market was a bit disappointed with Johnson & Johnson's (NYSE: JNJ - News) earnings, but after an early morning market sell-off, investors ultimately took the revenue miss in stride. Tomorrow's trading session will focus on Intel (Nasdaq: INTC - News), which reported strong results tonight, and JP Morgan (NYSE: JPM - News), which will announce its earnings early tomorrow morning. While today wasn't a great day for investors, the bullish momentum remains intact.

Related Quotes

SymbolPriceChange
CSCO23.740.00
Chart for Cisco Systems, Inc.
DPZ7.990.00
Chart for DOMINOS PIZZA INC
EMMS1.090.00
Chart for Emmis Communications Corporatio
FIG4.100.00
Chart for FORTRESS INV GP LLC
INTC19.390.00
Chart for Intel Corporation
{"s" : "csco,dpz,emms,fig,intc,jnj,jpm,ra,star","k" : "c10,l10,p20,t10","o" : "","j" : ""}

The Radio Stocks Index was the top performing tickerspy Index on the day, led by Emmis Communications Corp (Nasdaq: EMMS - News) with a 27% gain.

The market ended mixed, with the Nasdaq the only index able to squeeze out a gain, up 1 point to 2,140. The Dow fell -15 points to 9,871, while the S&P slipped -3 points to 1,073. Oil climbed 88 cents to $74.15 a barrel, while gold continued its march higher, up $7.50 to $1,065.00 an ounce.

In earnings news, healthcare giant Johnson & Johnson saw its Q3 net income rise 1% to $3.35 billion, or $1.20 per share, up from $3.31 billion, or $1.17 per share, a year ago. Revenue fell -5% to $15.08 billion. Analysts were looking for EPS of $1.13 on sales of $15.22 billion. The company raised its full-year fiscal 2010 outlook to adjusted EPS of $4.54-$4.59 from a prior forecast of $4.45-$4.55. The stock fell -2.4%. Nearly 900 Pro investors counted the stock among their top-15 holdings at the start of Q3.

Shares of Domino's Pizza (NYSE: DPZ - News) dropped -10.0% after the pizza delivery chain's Q3 top line fell short of the Wall Street consensus. For the period ended September 6th, the company earned $17.8 million, or 31 cents per share, up from $10.1 million, or 17 cents per share, a year earlier. Adjusted EPS came in at 17 cents, 2 cents ahead of analyst estimates. Revenue fell -7% to $302.7 million versus estimates of $308.9 million. Same-store sales were flat.

In M&A news, networking heavyweight Cisco (Nasdaq: CSCO - News) announced it will purchase Starent Network (Nasdaq: STAR - News) in an all cash deal. Cisco will pay $2.9 billion, or $35 a share, representing a 21% premium to Starent's closing price on Monday. The deal is expected to be dilutive to earnings in 2010 and 2011, before becoming accretive in 2012. Shares of Starent rose 16.8%. Twelve Pro investors counted Starent among their top-15 holdings at the start of Q3.

RailAmerica (NYSE: RA - News) had an inauspicious first day of trading, as the railroad freight operator fell -8.3%. The company, which was brought public by private equity firm Fortress Investment (NYSE: FIG - News), sold 22 million shares at $15 in its IPO. RailAmerica recorded a profit of $19.2 million on sales of $206.4 million in the first half of 2009. Fortress originally bought the company and took it private in 2007.

Fun and informative, tickerspy.com is a free investing website where you can track multiple stock portfolios and compare against 250 proprietary Indexes tracking themes from stem cells to green energy to precious metals. Best of all, tickerspy.com lets you spy on the portfolios of nearly 3,000 Wall Street institutions and hedge funds and see graphs of their performance. Try tickerspy.com today and find out how you stack up against investing legends like Warren Buffett!

Sponsored Links

Copyright © 2009 Indie Research. All rights reserved.